Crossmark

Sequential Exposure of Bortezomib and Vorinostat is Synergistic in Multiple Myeloma Cells

Published Online: 2017-01-18

Published Print: 2017-03

Authors

Nanavati, Charvi

Mager, Donald E.
Funding

Funding for this research was provided by:

National Institutes of Health
License Information

Text and Data Mining valid from 2017-01-18

Version of Record valid from 2017-01-18
More Information

Article History

Received: 26 September 2016

Accepted: 3 January 2017

First Online: 18 January 2017

Document is current